No abstract

Male goats of mating age serologically negative for Toxoplasma gondii were divided into three groups: GI - controls (placebo) (n = 2); GII - infected with 1 × 10(6) tachyzoites (RH strains) (n = 2); and GIII - infected with 2 × 10(5) oocysts (P strains) (n = 2). Clinical, hematology, parasite and serology tests and studies of parasites in the semen through bioassay and polymerase chain reaction (PCR), and in reproductive organs (bioassay) were performed to assess toxoplasma infection. Serological titers peaked at 4096 in two animal groups infected with the protozoan. The bioassays allowed an early detection of protozoa in semen samples of tachyzoite-inoculated animals. T. gondii DNA was identified through PCR in the semen in five (Days 5, 7, 28, 49, and 70) and two (both at day 56) different days post-inoculation in GII and GIII animals, respectively. It was also possible to detect T. gondii DNA in reproductive organs (prostate pool, testicles, seminal vesicle and epididymis) of goats inoculated with either tachyzoites or oocysts. The present study suggests the possibility of venereal transmission of T. gondii among goats and it should be further assessed.

No abstract

The present research aimed to describe possible histopathological alterations in the reproductive system (testicles and epididymis) of male dogs experimentally infected with

The aim this study was to evaluate the effect of the addition of LH in superovulatory response and embryo production in Santa Inês sheep. Ten donors with 60.3 ± 10.7 kg and BCS of 3.9 ± 0.3 were superovulated in a cross-over design, with a 60-day interval. Estrus was synchronized with a progesterone-releasing intravaginal device (CIDR™; Pfizer Animal Health, Brazil) inserted on Day 0 and replaced by a new one on Day 7, that was maintained to Day 14. Two doses of 37.5 g of D-cloprostenol (Prolise™, Arsa, Buenos Aires, Argentina) were administered, on Days 7 and 14. Donors also receive 256 mg of pFSH (Folltropin™, Bioniche, Belleville, ON, Canada) in 8 decreasing doses, starting on Day 12. On Day 14, all females received 200 IU of eCG (Novormon ™, Syntex, Argentina). On Day 15, the animals were homogeneously allocated in 1 of 2 groups: Control (GC, n = 10) and treated (G-LH, n = 10). Ewes in GC did not receive exogenous LH, whereas ewes in G-LH were treated with 7.5 mg of LH (Lutropin™, Bioniche), on Day 15. All females were inseminated by laparoscopy, with frozen–thawed semen, 42 and 48 h after CIDR removal. On Day 21, the embryos were surgically collected. The superovulatory response was classified in scores: (0) 4 or fewer CL; (1) between 5 and 10 CL, and (2) 11 or more CL. Means were compared using Kruskal-Wallis test and percentages using chi-square (P < 0.05). Most of donors (70%, 7/10) from G-LH presented a superovulatory response classified as score 2, and the remaining (30%, 3/10) as score 1, whereas, half of the controls were classified as score 2 and half as score 1. Ovulation rate tended to be greater in G-LH (135/158, 85.4% v. 105/135, 77.7%, P = 0.08). The number of CL (mean ± SD) was 10.5 ± 3.8 in GC and 13.5 ± 4.84 in G-LH, but was not statistically different. The number of anovulatory follicles (AF) did not differ between groups (GC: 3.0 ± 3.2; G-LH: 2.3 ± 1.6), but the proportion of AF tended to decrease in G-LH (30/135, 22.2% v. 23/158, 14.5%, P = 0.08). Considering embryo production, there was no difference between GC and G-LH (P > 0.05) related to number of recovered ova/embryos (6.1 ± 4.6 v. 8.4 ± 5.2), viable embryos (3.8 ± 4.3 v. 4.2 ± 5.2), unfertilized (1.7 ± 3.4 v. 2.0 ± 2.9) and degenerated embryos (0.7 ± 0.7 v. 2.2 ± 2.9), respectively. Data showed that the addition of LH tended to increase ovulation rate and to decrease the proportion of AF, but did not affect the number of viable embryos.